Literature DB >> 22477809

Thimerosal-containing vaccines and autism: a review of recent epidemiologic studies.

Anne M Hurley1, Mina Tadrous, Elizabeth S Miller.   

Abstract

Although epidemiologic evidence has not supported the hypothesis of a causal relationship between thimerosal-containing vaccines and autism, concerns continue about pediatric exposure to mercury through vaccine administration. A statement issued by the American Academy of Pediatrics and the US Public Health Service in 1999 prompted the removal of thimerosal from many vaccines. In 2004, the Immunization Safety Review Committee of the Institute of Medicine rejected the hypothesis of a causal relationship between thimerosal-containing vaccines and autism.In a search of MEDLINE and EMBASE, we identified articles that address the potential association between thimerosal and neurodevelopmental disorders, specifically autism. In this article, we review recent pharmacokinetic and epidemiologic studies published between 2003 and 2008 regarding the proposed link between thimerosal and autism.

Entities:  

Year:  2010        PMID: 22477809      PMCID: PMC3018252     

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  20 in total

1.  Recommendations regarding the use of vaccines that contain thimerosal as a preservative.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1999-11-05       Impact factor: 17.586

Review 2.  The screening and diagnosis of autistic spectrum disorders.

Authors:  P A Filipek; P J Accardo; G T Baranek; E H Cook; G Dawson; B Gordon; J S Gravel; C P Johnson; R J Kallen; S E Levy; N J Minshew; S Ozonoff; B M Prizant; I Rapin; S J Rogers; W L Stone; S Teplin; R F Tuchman; F R Volkmar
Journal:  J Autism Dev Disord       Date:  1999-12

3.  Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink.

Authors:  Heather A Young; David A Geier; Mark R Geier
Journal:  J Neurol Sci       Date:  2008-05-15       Impact factor: 3.181

4.  Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study.

Authors:  Michael E Pichichero; Elsa Cernichiari; Joseph Lopreiato; John Treanor
Journal:  Lancet       Date:  2002-11-30       Impact factor: 79.321

5.  Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.

Authors:  Nick Andrews; Elizabeth Miller; Andrew Grant; Julia Stowe; Velda Osborne; Brent Taylor
Journal:  Pediatrics       Date:  2004-09       Impact factor: 7.124

6.  Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.

Authors:  Jon Heron; Jean Golding
Journal:  Pediatrics       Date:  2004-09       Impact factor: 7.124

7.  Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data.

Authors:  Kreesten M Madsen; Marlene B Lauritsen; Carsten B Pedersen; Poul Thorsen; Anne-Marie Plesner; Peter H Andersen; Preben B Mortensen
Journal:  Pediatrics       Date:  2003-09       Impact factor: 7.124

Review 8.  Mercury exposure and public health.

Authors:  Jack C Clifton
Journal:  Pediatr Clin North Am       Date:  2007-04       Impact factor: 3.278

9.  Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.

Authors:  Michael E Pichichero; Angela Gentile; Norberto Giglio; Veronica Umido; Thomas Clarkson; Elsa Cernichiari; Grazyna Zareba; Carlos Gotelli; Mariano Gotelli; Lihan Yan; John Treanor
Journal:  Pediatrics       Date:  2008-02       Impact factor: 7.124

Review 10.  The three modern faces of mercury.

Authors:  Thomas W Clarkson
Journal:  Environ Health Perspect       Date:  2002-02       Impact factor: 9.031

View more
  6 in total

1.  Effects of Thimerosal on Lipid Bilayers and Human Erythrocytes: An In Vitro Study.

Authors:  Mario Suwalsky; Pablo Zambrano; María José Gallardo; Fernando Villena; Malgorzata Jemiola-Rzeminska; Kazimierz Strzalka
Journal:  J Membr Biol       Date:  2016-10-13       Impact factor: 1.843

2.  A Role for Gene-Environment Interactions in Autism Spectrum Disorder Is Supported by Variants in Genes Regulating the Effects of Exposure to Xenobiotics.

Authors:  João Xavier Santos; Célia Rasga; Ana Rita Marques; Hugo Martiniano; Muhammad Asif; Joana Vilela; Guiomar Oliveira; Lisete Sousa; Ana Nunes; Astrid M Vicente
Journal:  Front Neurosci       Date:  2022-05-19       Impact factor: 5.152

Review 3.  Environmental chemical exposures and autism spectrum disorders: a review of the epidemiological evidence.

Authors:  Amy E Kalkbrenner; Rebecca J Schmidt; Annie C Penlesky
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2014-09-05

4.  Fingerprinting of neurotoxic compounds using a mouse embryonic stem cell dual luminescence reporter assay.

Authors:  Marilena Colaianna; Sten Ilmjärv; Hedi Peterson; Ilse Kern; Stephanie Julien; Mathurin Baquié; Giorgia Pallocca; Sieto Bosgra; Agapios Sachinidis; Jan G Hengstler; Marcel Leist; Karl-Heinz Krause
Journal:  Arch Toxicol       Date:  2016-03-25       Impact factor: 5.153

5.  COVID-19 Anti-Vaccine Sentiments: Analyses of Comments from Social Media.

Authors:  Li Ping Wong; Yulan Lin; Haridah Alias; Sazaly Abu Bakar; Qinjian Zhao; Zhijian Hu
Journal:  Healthcare (Basel)       Date:  2021-11-09

6.  Biological properties the novel application of N-trimethyl chitosan nanospheres as a stabilizer and preservative in tetanus vaccine.

Authors:  Majdedin Ghalavand; Mojtaba Saadati; Jafar Salimian; Ebrahim Abbasi; Ghader Hosseinzadeh; Hadi Esmaeili Gouvarchin Ghaleh; Ali Ahmadi
Journal:  Clin Exp Vaccine Res       Date:  2021-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.